HealthcareServices

Autism Spectrum Disorder Diagnostics Market Forecast 2026–2035: How to Leverage Market Growth

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the autism spectrum disorder diagnostics market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Autism Spectrum Disorder Diagnostics Market be in 2030 compared with 2026?

The autism spectrum disorder diagnostics market has demonstrated substantial growth in recent years. It is anticipated to increase from $28.87 billion in 2025 to $30.37 billion in 2026, at a compound annual growth rate (CAGR) of 5.2%. This historical growth can be attributed to factors such as elevated awareness of autism spectrum disorders, the expansion of pediatric developmental screening programs, the availability of trained diagnostic professionals, the increasing utilization of behavioral assessment frameworks, and improved access to diagnostic services.

The autism spectrum disorder diagnostics market size is projected to experience consistent expansion in the coming years. This market is predicted to reach a valuation of $36.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. Several factors will drive this growth during the forecast period, including an increased need for early intervention services, wider adoption of AI-supported diagnostic tools, the broadening of tele-diagnostics platforms, enhanced investment in neurodevelopmental research, and better standardized diagnostic criteria. Key trends anticipated for this period encompass the surging uptake of digital screening tools, more frequent application of standardized behavioral assessment scales, the proliferation of diagnostic programs for early childhood, an increased blending of multidisciplinary diagnostic approaches, and a sharper emphasis on prompt and accurate detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16593&type=smp

What Drivers Are Guiding Growth Patterns In The Autism Spectrum Disorder Diagnostics Market?

The expansion of specialized diagnostic centers is anticipated to boost the autism spectrum disorders diagnostic market in the future. An autism-focused diagnostic center is an establishment comprising healthcare professionals, psychologists, and specialists who perform thorough evaluations and assessments for diagnosing autism spectrum disorder. The rise in these specialized centers stems from progress in diagnostics, the need for comprehensive care, specialized professional training, ongoing research, and the increasing acknowledgement of autism as a significant public health concern. These centers are crucial for enhancing diagnostic precision, enabling early intervention, and improving results for individuals with ASD by offering expert knowledge, advanced diagnostic instruments, thorough evaluations, personalized treatment strategies, family assistance, and opportunities for collaborative research. For example, in July 2025, NHS England, the U.K.-based government agency providing health services, announced the approval of 170 CDC sites across England under its national Community Diagnostic Centre (CDC) Programme. By August 2024, 165 sites were operational in various locations, with 135 functioning from their permanent CDC structures and the remainder operating temporarily while their permanent facilities are finalized. Consequently, the increasing number of specialized diagnostic centers is propelling the growth of the autism spectrum disorders diagnostic market.

Which Segments Are Driving Activity In The Autism Spectrum Disorder Diagnostics Market?

The autism spectrum disorder diagnostics market covered in this report is segmented –

1) By Diagnostic Method: Behavioral And Developmental Screening Tools, Standardized Diagnostic Assessments, Genetic And Molecular Testing, Digital And AI-Based Diagnostic Tools

2) By Test Type: Observational And Questionnaire-Based Tests, Cognitive And Neurodevelopmental Assessments, Biomarker And Genetic Tests, Eye-Tracking And Sensor-Based Tests

3) By Age Group: Infants And Toddlers (0–3 years), Children (4–12 years), Adolescents And Adults

4) By End User: Hospitals And Specialty Clinics, Diagnostic And Reference Laboratories, Academic And Research Institutes

Subsegments:

1) By Behavioral And Developmental Screening Tools: Parent-Reported Screening Questionnaires, Clinician-Administered Developmental Checklists

2) By Standardized Diagnostic Assessments: Structured Behavioral Observation Assessments, Standardized Diagnostic Interviews

3) By Genetic And Molecular Testing: Chromosomal Microarray Analysis (CMA), Next-Generation Sequencing (NGS) Panels

4) By Digital And AI-Based Diagnostic Tools: AI-Driven Behavioral Analysis Platforms, Digital Biomarker & Eye-Tracking Systems

What Trends Are Projected To Support The Growth Of The Autism Spectrum Disorder Diagnostics Market?

Companies engaged in the autism spectrum disorder diagnostics market are developing sophisticated solutions, such as devices leveraging Dynamic Quantification of Social-Visual Engagement (DQSVE), to achieve a competitive advantage. This technology meticulously records and examines a child’s moment-by-moment looking behavior at a rate of 120 times per second. For example, in September 2023, the Marcus Autism Center, a US-based nonprofit healthcare and research organization, introduced the EarliPoint™ Evaluation. This pioneering FDA-authorized device is specifically designed for the early diagnosis of autism spectrum disorder (ASD) in children aged 16 to 30 months. The innovative tool utilizes eye-tracking technology to assess children’s social interactions, considerably reducing the time needed for diagnosis from hours to approximately 12 minutes.

Which Major Firms Are Strengthening Their Position In The Autism Spectrum Disorder Diagnostics Market?

Major companies operating in the autism spectrum disorder diagnostics market are Quest Diagnostics, Laboratory Corporation of America LabCorp, ARUP Laboratories, Invitae, Natera, Fulgent Genetics, Myriad Genetics, Sema4, PreventionGenetics, Color Genomics, Cognoa, EarliTec Diagnostics, Eurofins Scientific, Sonic Healthcare, Cerba HealthCare, Baylor Genetics, Mayo Clinic Laboratories, Bionano Genomics, Genomind, Blueprint Genetics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/autism-spectrum-disorder-diagnostics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Autism Spectrum Disorder Diagnostics Market?

Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2025. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Autism Spectrum Disorder Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16593&type=smp

Browse Through More Reports Similar to the Global Autism Spectrum Disorder Diagnostics Market 2026, By The Business Research Company

Rare Disease Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report

Autism Spectrum Disorders Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/autism-spectrum-disorders-treatment-global-market-report

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795